Pfizer Inc. Hormone, Prempro Almost Double Breast Cancer Death Risk in U.S. Research

Bloomberg -- Pfizer Inc.’s Prempro, a hormone once used by millions of women to ease menopause symptoms, almost doubled the death risk from breast cancer, a U.S. study found.

MORE ON THIS TOPIC